Skip to content

PWAP Medical

Active
Private limited companyfounded 2024active for 2 yearsFaweux 90, 4920 Aywaille, BelgiumKBO/BCE: BE 1013.338.016
Summary

PWAP Medical has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €73,264 and a net result of €87,828. Its solvency ranks better than 22% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Official details

Source: KBO
Status
Active since 09-09-2024 Normal situation
Activity
Other human health activities NACE 86999and 1 other
Establishment unit
2.364.985.209 4920 Aywaille, since 09-09-2024
Financial year end
31 December
Peppol
Reachable since 05-01-2026

Board and ownership

Board

Financial position

81 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Annual accounts 2025
Gross margin
€116,479
▲ 490%
Turnover
≈ €230,000
estimated
Profit
€87,828
▲ 568%
Equity
€73,264
▲ 304%
Total assets
€315,882
▲ 445%
  • 2025 accounts filed 32 days after the deadline
Filed on 01-09-2026
Score breakdownraises riskLiquidity: current ratio 1.18, cash €530, halvedLast filed accounts filed 32 days late; 2 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Size: total assets €315,882Show the evidence

Checked score

Score 2025
81 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 50% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 48-8
equity 23.2% of total assets
Liquidity 8-47
short-term debt 76.8% · cash 0.2%
Profitability 100+6
return on assets 27.8%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 10-2025: < 0.1%lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.4%▲ +0.4 percentage points vs 03-2026 05-2026: 0.5%▲ +0.1 percentage points vs 04-2026 06-2026: 0.4%▼ -0.1 percentage points vs 05-2026 07-2026: 0.5%▲ +0.1 percentage points vs 06-2026 08-2026: 0.8%▲ +0.3 percentage points vs 07-2026 09-2026: 1.1%▲ +0.3 percentage points vs 08-2026highest value 10-2026: 0.6%▼ -0.5 percentage points vs 09-2026 11-2026: 0.6%● unchanged vs 10-2026
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.18 (1.46 in 2024), below the usual 1.5. Short-term debt is 76.8% and cash 0.2% of total assets. 76.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 22% of them on solvency, 1% on liquidity, 80% on profitability and 97% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 1.18, cash €530, halved
NBB · annual accounts
raises risk · Last filed accounts filed 32 days late; 2 of the last 3 accounts late
NBB · filings
lowers risk · Size: total assets €315,882
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 22%
← weakest strongest →
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
raises risk · 2025 accounts filed 32 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-09-2026, 32 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
32 days late
2024
236 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 134 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Positive: Result rose in 2025from €13,145 to €87,828 ▲ 568% View

Recent changes

  1. · Gazette deed IncorporationStarting capital €5,000 · Appointments: PRESTIA Alessandro (director) and PATTERSON William (director)
All 3 events

Comparable companies

These companies have the same main activity as PWAP Medical: other human health activities (NACE 86999). They are comparable in size and age: total assets between €121,000 and €384,000, founded between 2023 and 2025.

CompanyTotal assetsGross margin
PWAP Medical Aywaille€315,882€116,479
IasoD Stoumont€274,840€183,968
Oncia Community Ottignies-Louvain-la-Neuve€319,371€179,057
TRIPLE H SOLUTIONS Antwerpen€170,188€170,158
SpiroNath - LKC Braine-l'Alleud€384,122€312,339
Serafijnen Hoeilaart€220,542€50,560
VEKILEVA Vilvoorde€121,129€93,662
Full comparison

Key facts about PWAP Medical

What is the company number of PWAP Medical?
The company number of PWAP Medical is 1013.338.016. The VAT number is the same number with BE in front: BE 1013.338.016.
Where is PWAP Medical based?
The registered office is at Faweux 90, 4920 Aywaille.Company details
What does PWAP Medical do?
According to the KBO register, the main activity is other human health activities (NACE 86999).
What is the legal form of PWAP Medical?
The legal form of PWAP Medical is Private limited company (BV).
When was PWAP Medical founded?
PWAP Medical was founded on 09-09-2024.
Is PWAP Medical still active?
Yes, PWAP Medical is an active enterprise in the KBO register.
What is the turnover of PWAP Medical?
The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €116,479 and 82 comparable companies (NACE 86). It probably lies between €180,000 and €290,000. In financial year 2024 turnover was €0.Financials
Is PWAP Medical profitable?
In financial year 2025, PWAP Medical made a profit of €87,828.
Where can I find the annual accounts of PWAP Medical?
PWAP Medical filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PWAP Medical due?
PWAP Medical must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.